How it works, simply
It is derived from tuftsin and is proposed to influence several signaling pathways.
What the evidence tells us
The available research does not establish a broadly validated substitute for anxiety treatment.
Watch with PEP 7
A short introduction; the sources and limitations remain important.
Open video guide
Video guides are coming soon.
Risks and open questions
This guide does not establish a safe dose, interaction profile or long-term safety for self-use. Effects reported for one route or formulation may not apply to another.
Research and education only. PepGuide does not recommend medicines, doses or protocols.
Technical details and study context
Mechanism: Proposed anxiolytic and immune effects have limited and geographically narrow human evidence.
Sponsor or developer: No FDA-approved sponsor
Studied or labeled topics: Anxiety claims, Cognition claims
Commercial blend names and research vials do not inherit a medicine’s approval or manufacturing controls.
Sources and review dates
Product labels and further research
These directories help locate records. They are not individual studies supporting every statement.
Readability updated October 10, 2026. Evidence review: October 10, 2026 (FDA safety context only). A wording update is not a new clinical review.